ITRM

Iterum Therapeutics plc

1.19 USD
+0.04 (+3.48%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Iterum Therapeutics plc stock is down -19.59% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 6 June’s closed higher than May. 100% of analysts rate it a buy.

About Iterum Therapeutics plc

Iterum Therapeutics plc is developing sulopenem, a novel anti-infective compound with oral and IV formulations. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.